Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: Effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

Clinical and Vaccine Immunology

Volumn 17, Issue 5, 2010, Pages 840-847

  Campbell, Helen ^a   Andrews, Nick ^a   Borrow, Ray ^a   Trotter, Caroline ^b   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS SEROGROUP C CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; HERD IMMUNITY; HUMAN; MATHEMATICAL MODEL; MENINGOCOCCOSIS; PREDICTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CARRIER STATE; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; GREAT BRITAIN; HUMANS; IMMUNITY, HERD; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; MODELS, STATISTICAL; PRODUCT SURVEILLANCE, POSTMARKETING; WALES; YOUNG ADULT;

EID: 77952004260     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00529-09     Document Type: Article

References (39)

1. Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine using efficacy estimates from post-licensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786.
2. Auckland, C., S. Gray, R. Borrow, N. Andrews, D. Goldblatt, M. Ramsay, and E. Miller. 2006. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J. Infect. Dis. 194:1745-1752.
3. Barbour, M. L., R. T. Mayon-White, C. Coles, D. W. Crook, and E. R. Moxon. 1995. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 171:93-98.
4. Borrow, R., A. J. Fox, P. C. Richmond, S. Clark, F. Sadler, J. Findlow, R. Morris, N. T. Begg, and K. A. V. Cartwright. 2000. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine. Epidemiol. Infect. 124:427-432.
5. Borrow, R., N. Andrews, D. Goldblatt, and E. Miller. 2001. Serological basis for the use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect. Immun. 69:1568-1573.
6. Borrow, R., and G. M. Carlone. 2001. Serogroup B and C serum bactericidal assays. Methods Mol. Med. 66:289-304.
7. Borrow, R., D. Goldblatt, N. Andrews, J. Southern, L. Ashton, S. Deane, R. Morris, K. Cartwright, and E. Miller. 2002. Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom. J. Infect. Dis. 186:1353-1357.
8. Borrow, R., N. Andrews, H. Findlow, P. Waight, J. Southern, A. Crowley-Luke, L. Stapley, A. England, J. Findlow, and E. Miller. 2010. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin. Vaccine Immunol. 17:154-159.
9. Campbell, H., R. Borrow, D. Salisbury, and E. Miller. 2009. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 27S: B20-B29.
10. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. A. V. Cartwright. 1996. Reactogenicity and immunogenicity of conjugate meningococcal serogroup A and C vaccine in UK infants. J. Infect. Dis. 174:1360-1363.
11. Farrington, P., and E. Miller. 2001. Meningococcal vaccine trials, p. 23-40. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal vaccines: methods and protocols. Humana Press, Totowa, NJ.
12. Farrington, C. P. 1995. Estimation of vaccine effectiveness using the screening method. Int. J. Epidemiol. 22:742-746.
13. Goldblatt, D., E. Miller, N. McCloskey, and K. Cartwright. 1998. Immunological response to conjugate vaccines in infants: follow up study. BMJ 316:1570-1571. (Pubitemid 28234098)
14. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
15. Gray, S. J., C. L. Trotter, M. E. Ramsay, M. Guiver, A. J. Fox, R. Borrow, R. H. Mallard, and E. B. Kaczmarski. 2006. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J. Med. Microbiol. 55:887-896.
16. Johnson, N. G., J. U. Ruggeberg, G. F. Balfour, Y. C. Lee, H. Liddy, D. Irving, J. Sheldon, M. P. Slack, A. J. Pollard, and P. T. Heath. 2006. Haemophilus influenzae type b reemergence after combination immunization. Emerg. Infect. Dis. 12:937-941.
17. MacLennan, J. M., F. Shackley, P. T. Heath, J. J. Deeks, C. Flamank, M. Herbert, H. Griffiths, E. Hatzmann, C. Goilav, and E. R. Moxon. 2000. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized control trial. JAMA 283:2795-2801.
18. Maiden, M. C., and J. M. Stuart, for the Meningococcal Carriage Group. 2002. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccine. Lancet 359:1829-1831.
19. Maiden, M. C., A. B. Ibarz-Pavón, R. Urwin, S. J. Gray, N. J. Andrews, S. C. Clarke, A. M. Walker, M. R. Evans, J. S. Kroll, K. R. Neal, D. A. Ala'aldeen, D. W. Crook, K. Cann, S. Harrison, R. Cunningham, D. Baxter, E. Kaczmarski, J. Maclennan, J. C. Cameron, and J. M. Stuart. 2008. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197:737-743.
20. McVernon, J., A. J. Howard, M. P. Slack, and M. E. Ramsay. 2004. Longterm impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol. Infect. 132:765-767.
21. McVernon, J., P. D. Johnson, A. Pollard, M. P. Slack, and E. R. Moxon. 2003. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. Arch. Dis. Child. 88:379-383.
22. Miller, E., D. Salisbury, and M. Ramsay. 2001. Planning, registration and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(Suppl. 1):S58-S67.
23. Ramsay, M. E., J. McVernon, N. J. Andrews, P. T. Heath, and M. P. Slack. 2003. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J. Infect. Dis. 188:481-485.
24. Ramsay, M. E., N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller. 2003. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 326:365-366.
25. Ramsay, M. E., E. Miller, N. Andrews, M. Slack, and P. Heath. 2004. Epidemiological data are essential. BMJ http://www.bmj.com/cgi/eletters/330/ 7481/18. (Rapid response.)
26. Richmond, P. C., E. Miller, R. Borrow, S. Clark, F. Sadler, and A. J. Fox. 1999. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 179:1569-1572.
27. Richmond, P., R. Borrow, D. Goldblatt, J. Findlow, D. Martin, R. Morris, K. Cartwright, and E. Miller. 2001. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J. Infect. Dis. 183:160-163.
28. Snape, M. D., D. F. Kelly, S. Lewis, C. Banner, L. Kibwana, C. E. Moore, L. Diggle, T. John, L. M. Yu, R. Borrow, A. Borkowski, C. Nau, and A. J. Pollard. 2008. Seroprotection against serogroup C meningococcal disease in adolescents in the UK: observational study. BMJ 336:1487-1491.
29. Southern, J., A. Crowley-Luke, R. Borrow, N. Andrews, and E. Miller. 2006. Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine. Vaccine 24:215-219.
30. Southern, J., J. McVernon, D. Gelb, N. Andrews, R. Morris, A. Crowley- Luke, D. Goldblatt, and E. Miller. 2007. Immunogenicity of a fourth dose of Haemophilus influenzae type B (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy. Clin. Vaccine Immunol. 14:1328-1333.
31. Southern, J., R. Borrow, N. Andrews, R. Morris, P. Waight, M. Hudson, P. Balmer, H. Findlow, J. Findlow, and E. Miller. 2009. Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom. Clin. Vaccine Immunol. 16:194-199.
32. Trotter, C. L., M. E. Ramsay, and E. B. Kaczmarski. 2002. Meningococcal serogroup C vaccination in England and Wales: coverage and initial impact of the campaign. Commun. Dis. Public Health 5:220-225.
33. Trotter, C. L., and W. J. Edmunds. 2002. The cost-effectiveness of the meningococcal group C conjugate vaccination campaign in England and Wales. BMJ 324:809.
34. Trotter, C., N. Andrews, R. Borrow, and E. Miller. 2003. Seroprevalence of meningococcal serogroup C antibody in England and Wales in the prevaccination era. Vaccine 21:1094-1098. (Pubitemid 36139939)
35. Trotter, C., N. Andrews, E. Kaczmarski, E. Miller, and M. Ramsay. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365-367.
36. Trotter, C. L., N. J. Gay, and W. J. Edmunds. 2005. Dynamic models of meningococcal carriage, disease and the impact of serogroup C conjugate vaccination. Am. J. Epidemiol. 162:89-100.
37. Trotter, C. L., W. J. Edmunds, M. E. Ramsay, and E. Miller. 2006. Modelling future changes to the meningococcal serogroup C (MCC) vaccination programme in England and Wales. Hum. Vaccines 2:68-73.
38. Trotter, C. L., N. J. Gay, and W. J. Edmunds. 2006. Natural history of meningococcal carriage and disease. Epidemiol. Infect. 134:556-566.
39. Trotter, C. L., R. Borrow, J. Findlow, A. Holland, S. Frankland, N. J. Andrews, and E. Miller. 2008. Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era. Clin. Vaccine Immunol. 15:1694-1698.